Morning Overview on MSN
FDA clears first US trial of Motif’s wireless brain implant for depression
A coin-sized device with no battery, no wires, and no deep surgical penetration into the brain just cleared its biggest ...
A wireless brain implant for treatment-resistant depression has received FDA clearance for human trials in the United States.
MintNeuro, a pioneer of scalable, low-power semiconductor technology for neural implant applications, and Motif Neurotech, a therapeutic brain-computer interface (BCI) company developing miniature ...
By integrating sub-50ms end-to-end latency with BCI-driven functional electrical stimulation (BCI-FES), the system enables a ...
A new research paper argues that emerging brain–computer interface (BCI) technologies are not just medical tools but ...
The FDA has authorized the first human trial of a brain-computer interface designed to treat severe, treatment-resistant depression. Created by Motif Neurotech, the small implant works with a wireless ...
MintNeuro and Motif Neurotech have announced a strategic partnership aimed at advancing miniature brain-computer interface ...
A research team has published details of a brain-computer interface that abandons the conventional approach of ...
Highly anticipated: As the brain-computer interface technology field transitions from experimental demonstrations to practical clinical applications, the University of Michigan has just achieved a ...
Implantation of a brain-computer interface (BCI) into tetraplegic participants allowed for consistent control of a robotic arm and hand for reaching and grasping, according to a study performed at the ...
ANN ARBOR, MI -- One of the first brain-computer interface clinics in the country has opened in Ann Arbor. University of Michigan Health opened its clinic to patients with severe motor and speech ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results